On Tuesday 20th February, at Science14 (14b Rue de la Science – Brussels), from 17:00 to 20:00 the closed-door roundtable “THE RISKS OF THE IP FRAMEWORK REVISION”, organized by the Institute for Competitiveness, took place. The IP framework is deeply linked to the pharmaceutical innovation, helping investments and improving the health system. Should the EU revise the IP framework as forecasted? The roundtable aimed at facing the positions of the European bodies on this topic.
